@GroupKyte
 Oslo, Norway
ous-research.no/kyte/
Joined November 2019
  • Tweets68
  • Following63
  • Followers191
28Media
Vi gratulerer Johanna Olweus & The Matchmakers som er en av fem vinnere av Cancer Grand Challenges og får 250 millioner til å løse en av de store utfordringene unnen kreftforskning instagram.com/reel/C5QKl28h4…

Oslo universitetssykehus (@oushf) • Instagram reel

instagram.com
2
3
78
Congratulations to Andreas Røssevold MD, PhD with his fantastic PhD defence and discussion over the outcomes of the Alice snd Icon trials @GroupKyte @UniOslo_MED @RESCUER2020
1
6
303
In patients with metastatic triple-negative #BreastCancer, atezolizumab + anthracycline-based chemotherapy improves progression-free survival, including in PD-L1 negative disease #SABCS22 @andreashr @GroupKyte @AmundJon @Oslounivsykehus @UniOslo_MED #BCsm nature.com/articles/s41591-0…
13
5
30
Here is a little summary of my talk at #ESMO2022 and chat with @HealthTalkNorge in Norwegian on how we have built a #precisiononcology initiative for Norway. @HellandAslaug @HRussnes @livefagereng @RgoElisa @asmundflobak @DrLB @DrFrich healthtalk.no/esmo-impress-n…

Presenterer norsk kreftinitiativ på ESMO

Resultatene som er oppnådd i et storstilt privat-offentlig samarbeid for å ta i bruk presisjonsmedisin på kreftområdet, er nå presentert på kreftkongressen ESMO.

healthtalk.no
8
21
The waterfall plot that wins ESMO! Well done @MyriamChalabi! #ESMO22 @myESMO
7
92
11
452
Great to meet so many interested in clinical studies and further collaboration!
Kjetil Tasken@KjetilTasken9 Sep 2022
#Nortrials will have focus-areas cancer, gastrointestinale, cardiovascular, inflammatory and neurological diseases and medical devices. Here from the opening with #SigneØienFretland at the coordinating unit and @HellandAslaug for Nortrials-Cancer. @Oslounivsykehus @OsloCancer
2
9
Transcriptomic and proteomic profiling of #breastcancer biopsies identifies baseline features of the tumor immune microenvironment associated with T cell clonal expansion following neoadjuvant anti-PD-1 treatment. nature.com/articles/s41591-0… #THPT21 @LambrechtsDlab @vib_ccb
48
11
97
Kyte Group retweeted
Live@livefagereng26 Apr 2021
Oslo universitetssykehus er åpnet som studiesenter i #impressnorway. Gratulerer team OUS @HellandAslaug @KjetilTasken @GroupKyte @HRussnes impressnorway.com

IMPRESS-Norway - Forsiden - IMPRESSNorway

IMPRESS-Norway – en nasjonal klinisk kreft studie Målet med studien er at pasienter skal få tilgang til ny kreftbehandling basert på molekylære forandringer i kreftsvulsten. Om studien Deltakende...

impress-norway.no
1
4
2
12
Nice retreat with the Dept. of Cancer Immunology, ICR @Oslounivsykehus today. Many excellent talks and lots of discussion. Also fun games - and the Team basofils won before the T cells and macrophage teams! @UniOslo_MED @JCITnews @kg_cell @TaskenLab @MalmbergLab @JOlweus
4
1
17
Informative lecture by Dr. Saheli Sadanand, the associate editor at Nature Medicine and great discussion afterward. @SaheliSadanand @NatureMedicine @OsloCancer @GroupKyte
1
1
Great talks in Cancer Immunotherapy Nobel Laureate Jim Allison, Padmanee Sharma, and Cassian Yee @MDAndersonNews @OsloCancer @tcellsrus
2
1
18
Kyte Group retweeted
Bjørn Klem@BnKlem7 Feb 2019
Kreftpasienter skal få bedre tilgang til eksperimentell kreftbehandling. Utprøvingsenheten ved OUS Radiumhospitalet med ny leder Jon Amund Lyte og @OsloCancer skal bidra aktivt til dette @siva_sf @InnovasjonNorge @forskningsradet
6
19
Load more